The Center for Safe Internet Pharmacies strives to stay on top of the latest topics, trends and developments related to counterfeit online medicines and illegitimate internet pharmacies. This page will also be updated with CSIP happenings, as well as news from our members and ex-officio member.
Even prior to the pandemic, community-based pharmacies have been essential sources of care and support for families, especially those most in need of resources for accessing health care, food, financial assistance, etc. According to the Centers for Disease Control and Prevention, community pharmacies are located in most communities in the US and more than 90% of the US population live within 5 miles of one. They are frequented more than the primary care provider’s office and this has been further heightened by COVID-19. While traditional visits to the doctor or hospital have been hindered or moved to telehealth, the local pharmacy has been a source of not only pandemic-specific health and safety information, but also guidance for managing chronic diseases. Read More
Did you know that in a 2019 survey by the American Board of Pain Medicine 92% of pain specialists “reported that they were required to submit a prior authorization for non-opioid pain care, which delayed patient treatment”? Non-opioid pain care includes occupational or physical therapy and non-opioid medications, treatments, creams, or patches. This barrier and more are what lead the American Medical Association (AMA) to recently recommend that states partner with universities and health systems to support “access to evidence-based interdisciplinary pain management delivery models” and that insurance companies review the coverage for these treatment protocols so they are on par with opioid coverage and patients are able to get the care they need. Read More
As 2020 came to an end, the American Medical Association (AMA) collaborated with Manatt Health to release its updated National Roadmap on State-Level Efforts to End the Nation’s Drug Overdose Epidemic. The roadmap offers best practices and needed next steps to improve access to patient care and prevent deaths from overdoses. The coronavirus disease 2019 (COVID-19) pandemic has further heightened the challenges with opioid addiction and overdose. According to the US Centers for Disease Control and Prevention (CDC), over 81,000 overdose deaths occurred in the US in the period between May 2019 and May 2020 – the highest number ever recorded in a 12 month timeframe. Read More